OTC Viagra too risky, says EMEA
This article was originally published in Scrip
Executive Summary
An OTC presentation of Pfizer's Viagra (sildenafil) would be too risky at this point, said the EU's CHMP around the time Pfizer withdrew its application to switch the product to non-prescription status.
You may also be interested in...
UK: Commercial Framework Sheds Light On Working With NHS And NICE
The final text brings some changes, including the introduction of an escalation process when companies and NHS England cannot agree.
Time Is Ripe For Global Action On Orphan Biosimilars
European industry association wants global convergence on development requirements, though the European Medicines Agency says that this would prove challenging.
Time Is Ripe For Global Action On Orphan Biosimilars
European industry association wants global convergence on development requirements, though the European Medicines Agency says that this would prove challenging.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports